Research Analysts Offer Predictions for Clorox Q3 Earnings

The Clorox Company (NYSE:CLX) – Analysts at Zacks Research reduced their Q3 2025 earnings estimates for shares of Clorox in a research report issued to clients and investors on Monday, February 17th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $1.60 per share for the quarter, down from their previous estimate of $1.68. The consensus estimate for Clorox’s current full-year earnings is $7.15 per share. Zacks Research also issued estimates for Clorox’s Q4 2025 earnings at $2.14 EPS, FY2025 earnings at $7.15 EPS, Q1 2026 earnings at $1.63 EPS, Q2 2026 earnings at $1.64 EPS, Q3 2026 earnings at $1.66 EPS, FY2026 earnings at $7.12 EPS, Q1 2027 earnings at $1.74 EPS, Q2 2027 earnings at $1.76 EPS and FY2027 earnings at $7.64 EPS.

Several other analysts have also recently weighed in on CLX. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. JPMorgan Chase & Co. upped their price target on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. DA Davidson lowered their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Evercore ISI upped their price target on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $158.21.

Clorox Stock Up 0.1 %

Shares of NYSE CLX opened at $148.11 on Wednesday. The firm’s 50-day simple moving average is $158.78 and its 200 day simple moving average is $159.71. The company has a market cap of $18.33 billion, a price-to-earnings ratio of 40.47, a price-to-earnings-growth ratio of 2.53 and a beta of 0.42. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. Clorox has a 12-month low of $127.60 and a 12-month high of $171.37.

Clorox (NYSE:CLX) last issued its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the firm posted $2.16 EPS.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Mizuho Securities USA LLC grew its position in Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after acquiring an additional 4,490,421 shares during the last quarter. Norges Bank bought a new position in Clorox in the fourth quarter valued at about $259,041,000. FMR LLC grew its position in Clorox by 75.4% in the fourth quarter. FMR LLC now owns 1,361,758 shares of the company’s stock valued at $221,163,000 after acquiring an additional 585,526 shares during the last quarter. Marshall Wace LLP grew its position in Clorox by 549.8% in the fourth quarter. Marshall Wace LLP now owns 542,726 shares of the company’s stock valued at $88,144,000 after acquiring an additional 459,203 shares during the last quarter. Finally, ExodusPoint Capital Management LP grew its holdings in shares of Clorox by 187.9% during the fourth quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company’s stock worth $113,508,000 after purchasing an additional 456,114 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.